Advantages and pitfalls of combining device-based and pharmacologic therapies for the treatment of ventricular arrhythmias: observations from a tertiary referral center

Pacing Clin Electrophysiol. 2004 Dec;27(12):1670-81. doi: 10.1111/j.1540-8159.2004.00702.x.
No abstract available

MeSH terms

  • Amiodarone / adverse effects
  • Amiodarone / therapeutic use
  • Anti-Arrhythmia Agents / adverse effects*
  • Anti-Arrhythmia Agents / therapeutic use
  • Bradycardia / etiology
  • Bradycardia / therapy
  • Combined Modality Therapy
  • Defibrillators, Implantable / adverse effects*
  • Drug Interactions
  • Humans
  • Hydantoins
  • Imidazolidines / adverse effects
  • Imidazolidines / therapeutic use
  • Pacemaker, Artificial
  • Piperazines / adverse effects
  • Piperazines / therapeutic use
  • Sotalol / adverse effects
  • Sotalol / therapeutic use
  • Tachycardia, Ventricular / therapy*
  • Treatment Outcome

Substances

  • Anti-Arrhythmia Agents
  • Hydantoins
  • Imidazolidines
  • Piperazines
  • azimilide
  • Sotalol
  • Amiodarone